Federal Supply Schedule 36F79720D0105

Award Date 3/15/20
Last Date to Order 3/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Pharmaessentia USA Corp, a foreign-owned for-profit organization. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a ceiling value of $6,000,000.00 and a period of performance from June 1, 2022 to May...
The Federal Supply Schedule (FSS) contract award with ID 36F79723D0101 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a maximum value of $500,000.00 and a period of performance from April 1, 2023 to March 31, 2028. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The prime contractor awarded this multiple-award contract...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs, provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Unipack LLC, a minority-owned, for-profit manufacturer doing business as US Pharmaceuticals. The contract has a ceiling value of $225,000.00 and a period of performance through August 14, 2025. It was awarded under the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,980,000.00 and a period of performance that runs through January 1, 2026. The contracted products and services under this multiple award FSS-61-IB schedule include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Llorens Pharmaceutical International...
This is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Ajanta Pharma USA Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance from December 2, 2024 to May 31, 2025. As a Federal Supply Schedule contract, this vehicle allows VISN 12, which is a civilian federal agency, to procure pharmaceutical and...
The Federal Supply Schedule contract award 36F79719D0259 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to the prime contractor Antares Pharma Inc. The contract, categorized under FSS-61-IB for Pharmaceuticals and Drugs, has a ceiling value of $8,334,100.00 and a period of performance through September 14, 2025. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products from the manufacturer Antares Pharma...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Pharmaceuticals and Drugs (FSS-61-IB) to the agency's Veterans Integrated Service Network 12. The prime contractor, Avion Pharmaceuticals, LLC, was awarded this multiple-award contract with a ceiling value of $675,000.00 and a period of performance through December 31, 2025. The contracted products and services encompass a broad range of pharmaceutical and hematology-related items....

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026.

The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services Administration (GSA) Pharmaceutical and Drugs schedule (FSS-61-IB). The contract is a multiple award and does not utilize any set-asides. The contract aims to provide VISN 12 with a reliable source of critical pharmaceutical and drug products to support its healthcare services for U.S. veterans. The contract's broad scope and lengthy period of performance suggest it is a strategic procurement vehicle intended to meet the agency's ongoing pharmaceutical needs.

Generated 3/5/25, 9:53 AM